Evidence map›Paper›PMID 40176836›Full record

ArticleMolecular syndromology2025

Discovery of a Novel

Yavuzhan Colak, Mustafa Yilmaz, Pinar Ozkan Kart, Kerem Terali, Ayberk Turkyilmaz, Ali Cansu

Abstract readCase Reports
In one paragraph

Article in Molecular syndromology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yavuzhan ColakDepartment of Medical Genetics, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.
Mustafa YilmazDepartment of Medical Genetics, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.
Pinar Ozkan KartClinics of Pediatric Neurology, Trabzon Kanuni Training and Research Hospital, Health Science University, Trabzon, Turkey.
Kerem TeraliDepartment of Medical Biochemistry, Cyprus International University Faculty of Medicine, Nicosia, Cyprus.
Ayberk TurkyilmazDepartment of Medical Genetics, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.
Ali CansuDepartment of Pediatric Neurology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cullin-3, encoded by the Case Presentation: A 7-year-old patient with seizure, speech delay, decreased eye contact, and autistic behaviors was referred to our clinic. The patient was evaluated through clinical examination, laboratory tests, and imaging studies. Physical examination revealed extremity findings (brachydactyly, tapering fingers). Single whole-exome sequencing analysis was performed for clinical diagnosis. A novel missense variant, c.368T>A (p.Leu123Gln) in Conclusion: By presenting the first Turkish case of a novel missense variant with a CUL3-related NEDAUS phenotype, this study contributes to the expansion of the genotypic and phenotypic spectrum of the disease.

Indexed as

CUL3Cullin-3Language impairmentNEDAUS phenotypeWhole-exome sequencing

Identifiers

PMID40176836
PMCPMC11961091

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.